Lumenis Launches Stellar M22 Platform Featuring XPL Technology
The latest iteration of the multi-application platform adds new pulsed-light features and is approved to treat over 30 indications for skin and hair removal.
The latest iteration of the multi-application platform adds new pulsed-light features and is approved to treat over 30 indications for skin and hair removal.
The latest version features increased energy output, interchangeable spot sizes, and system upgrades aimed at enhancing multi-modal aesthetic treatments.
A new analysis points to aging patients, rising med-spa volume, and next-generation HA and biostimulatory formulas as drivers behind the projected jump to an $8.45B global fillers market.